Amneal Pharmaceuticals Inc.

Global biopharma firm developing generics, biosimilars, and specialty CNS/endo drugs—Rytary, CREXONT, Unithroid—while delivering medical products to U.S., DOD, VA, and international markets.

Headquarters: United States (USA)

Amneal Pharmaceuticals Inc. Logo
Company Profile
  • Employees: 8,300
  • HQ: Bridgewater
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
AMRX Amneal Pharmaceuticals Inc.
Cap: 4.1B | P/E: 1296.0
EQUITY NYQ USD US03168L1052 Active
📈
Home Login